Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,049,767,127
+$52,343,382 QoQ
Shares Held
8,169,394
-1.5% QoQ
Ownership
0.331%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#35
of 3,762 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 6%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. MRK ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,049,767,127 | 8,169,394 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $997,423,745 | 8,291,826 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $899,664,480 | 8,547,069 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $731,943,790 | 8,720,884 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $614,054,804 | 7,757,135 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $668,266,607 | 7,445,038 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $732,382,003 | 7,362,103 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $796,538,794 | 7,014,255 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $867,354,558 | 7,006,095 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $928,675,841 | 7,038,089 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $741,058,104 | 6,797,451 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $703,625,568 | 6,834,634 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $796,955,685 | 6,906,627 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $794,868,836 | 7,471,274 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $904,265,352 | 8,150,206 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $703,890,708 | 8,173,371 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $679,858,789 | 7,457,045 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $609,574,965 | 7,429,311 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $543,029,880 | 7,085,463 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $528,216,480 | 7,032,572 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $506,714,787 | 6,515,556 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $501,206,298 | 6,501,570 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $463,180,427 | 5,662,355 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $449,080,141 | 5,413,863 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $411,342,959 | 5,319,317 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $393,762,057 | 5,117,783 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||